• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzopyrazoles Indazoles

Comprehensive Overview of 7-Bromo-2,3-dimethyl-2H-indazole (CAS No. 845751-62-4): Properties, Applications, and Research Insights

7-Bromo-2,3-dimethyl-2H-indazole (CAS No. 845751-62-4) is a specialized heterocyclic compound that has garnered significant attention in pharmaceutical and agrochemical research due to its unique structural features. As a brominated indazole derivative, this compound serves as a versatile intermediate in organic synthesis, particularly in the development of bioactive molecules. Researchers are increasingly exploring its potential in drug discovery, with studies focusing on its role as a kinase inhibitor scaffold and its applications in cancer therapeutics.

The molecular structure of 7-Bromo-2,3-dimethyl-2H-indazole features a bromine atom at the 7-position and methyl groups at the 2- and 3-positions of the indazole ring system. This specific substitution pattern enhances its reactivity in cross-coupling reactions, making it valuable for palladium-catalyzed transformations such as Suzuki-Miyaura and Buchwald-Hartwig couplings. Recent publications highlight its utility in constructing polycyclic aromatic systems, which are crucial for developing fluorescence probes and organic electronic materials.

In the context of current research trends, 7-Bromo-2,3-dimethyl-2H-indazole aligns with the growing demand for small molecule modulators in targeted therapy. Its structural similarity to known allosteric inhibitors has prompted investigations into its potential interactions with protein-protein interfaces, a hot topic in precision medicine development. Analytical techniques like HPLC-MS and NMR spectroscopy are routinely employed to characterize this compound, ensuring high purity for research applications.

The compound's stability under various conditions makes it suitable for high-throughput screening platforms. Recent patent literature reveals its incorporation into combinatorial libraries for identifying novel enzyme inhibitors. Notably, its lipophilicity profile (calculated LogP ≈ 2.8) suggests favorable cell membrane permeability, a critical factor in bioavailability optimization studies. These properties position 7-Bromo-2,3-dimethyl-2H-indazole as a valuable building block in medicinal chemistry campaigns.

From a synthetic chemistry perspective, the bromine atom in 7-Bromo-2,3-dimethyl-2H-indazole serves as an excellent handle for further functionalization. This characteristic has led to its use in developing molecular probes for studying signal transduction pathways. The compound's thermal stability (decomposition temperature >200°C) also makes it compatible with various microwave-assisted synthesis techniques, which are gaining popularity for green chemistry applications.

Quality control protocols for 7-Bromo-2,3-dimethyl-2H-indazole typically involve chromatographic purity assessments (>98%) and residual solvent analysis to meet ICH guidelines. The compound's crystalline nature facilitates characterization by X-ray diffraction, providing valuable data for structure-activity relationship (SAR) studies. These rigorous standards ensure reproducibility in lead optimization processes across different research institutions.

Emerging applications of 7-Bromo-2,3-dimethyl-2H-indazole include its use in developing PET radiotracers for molecular imaging, leveraging the bromine atom for isotope exchange strategies. This aligns with current interests in theranostic agents that combine diagnostic and therapeutic functions. Additionally, computational studies utilizing molecular docking and QSAR modeling frequently employ this scaffold to explore novel binding motifs in drug design.

Handling and storage recommendations for 7-Bromo-2,3-dimethyl-2H-indazole emphasize protection from moisture and light exposure to maintain stability. Standard laboratory safety protocols apply when working with this compound, including the use of personal protective equipment (PPE) and proper ventilation systems. These precautions align with broader industry trends toward responsible research practices in chemical synthesis.

The commercial availability of 7-Bromo-2,3-dimethyl-2H-indazole through specialized chemical suppliers has expanded its accessibility to researchers worldwide. Current market analyses indicate growing demand from contract research organizations (CROs) engaged in fragment-based drug discovery. This trend reflects the compound's importance in addressing contemporary challenges in hit-to-lead development pipelines.

Future research directions for 7-Bromo-2,3-dimethyl-2H-indazole may explore its potential in proteolysis targeting chimera (PROTAC) design and other targeted protein degradation strategies. The compound's modular structure offers opportunities for creating bifunctional molecules that can engage multiple biological targets simultaneously—an approach gaining traction in complex disease treatment paradigms.

• 1182284-35-0(2H-Indazole-3-carbonitrile, 6-bromo-2-methyl-)
• 552331-30-3(5-Bromo-1,3-dimethyl-1H-indazole)
• 845751-70-4(7-Bromo-2-methyl-2H-indazole-3-carbaldehyde)
• 1159511-75-7(7-Bromo-3-methyl-1H-indazole)
• 1095539-84-6(6-Bromo-1,3-dimethyl-1H-indazole)
• 1251023-52-5(5-bromo-2-methyl-indazole-3-carbaldehyde)
• 1142189-49-8(6-Bromo-2,3-dimethyl-2H-indazole)
• 1159511-84-8(7-Bromo-1,3-dimethyl-1H-indazole)
• 50407-18-6(2,3-dimethyl-2H-indazole)
• 878064-16-5(5-Bromo-2,3-dimethyl-2H-indazole)